Biography

Geoffrey M. Glass has been a member of the Board of Directors since July 2018 and became Chairman of the Board in December 2018. Geoff is the founder and CEO of Kiniciti, a company focused on accelerating the advancement of the cell and gene therapy sector. Geoff has spent over 25 years helping lead services and therapeutic companies in the Life Sciences sector. Having begun his career at EY in their consulting practice, Geoff spent nearly 10 years running major accounts and practice areas for the firm. During his time at Valeant Pharmaceuticals (now Bausch Health), Geoff served on the executive team for nearly five years, first as CIO and then running Valeant’s Asia business. In 2009, he was recruited to help lead the turn-around of Patheon. While at Patheon, Geoff had leadership of Strategy, Corporate Development, Sales, Marketing, Pricing, Contracting and ended his tenure as the President of the Banner Life Sciences division. Following almost seven years at Patheon, Geoff was CEO of Sancilio Pharmaceuticals and worked with many private equity groups, including as Operating Partner at LongueVue Capital.